180 related articles for article (PubMed ID: 12727559)
1. Normal mammography and ultrasonography in the setting of palpable breast cancer.
Beyer T; Moonka R
Am J Surg; 2003 May; 185(5):416-9. PubMed ID: 12727559
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of abnormal mammography results and palpable breast abnormalities.
Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
[TBL] [Abstract][Full Text] [Related]
3. Utility and Outcomes of Imaging Evaluation for Palpable Lumps in the Postmastectomy Patient.
Dashevsky BZ; Hayward JH; Woodard GA; Joe BN; Lee AY
AJR Am J Roentgenol; 2019 Aug; 213(2):464-472. PubMed ID: 31039027
[No Abstract] [Full Text] [Related]
4. New Palpable Breast Lump With Recent Negative Mammogram: Is Repeat Mammography Necessary?
Leung SE; Ben-Nachum I; Kornecki A
AJR Am J Roentgenol; 2016 Jul; 207(1):200-4. PubMed ID: 27081707
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?
Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA
Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217
[TBL] [Abstract][Full Text] [Related]
6. The anatomy of missed breast cancers.
Reintgen D; Berman C; Cox C; Baekey P; Nicosia S; Greenberg H; Bush C; Lyman GH; Clark RA
Surg Oncol; 1993; 2(1):65-75. PubMed ID: 8252194
[TBL] [Abstract][Full Text] [Related]
7. Negative predictive value of sonography with mammography in patients with palpable breast lesions.
Soo MS; Rosen EL; Baker JA; Vo TT; Boyd BA
AJR Am J Roentgenol; 2001 Nov; 177(5):1167-70. PubMed ID: 11641195
[TBL] [Abstract][Full Text] [Related]
8. Utility of Diagnostic Mammography as the Primary Imaging Modality for Palpable Lumps in Women With Almost Entirely Fatty Breasts.
Linden OE; Hayward JH; Price ER; Kelil T; Joe BN; Lee AY
AJR Am J Roentgenol; 2020 Apr; 214(4):938-944. PubMed ID: 32023120
[No Abstract] [Full Text] [Related]
9. Clinically palpable breast abnormalities with normal imaging: is clinically guided biopsy still required?
Gumus H; Gumus M; Mills P; Fish D; Devalia H; Jones SE; Jones PA; Sever AR
Clin Radiol; 2012 May; 67(5):437-40. PubMed ID: 22119297
[TBL] [Abstract][Full Text] [Related]
10. US as the Primary Imaging Modality in the Evaluation of Palpable Breast Masses in Breastfeeding Women, Including Those of Advanced Maternal Age.
Chung M; Hayward JH; Woodard GA; Knobel A; Greenwood HI; Ray KM; Joe BN; Lee AY
Radiology; 2020 Nov; 297(2):316-324. PubMed ID: 32870133
[TBL] [Abstract][Full Text] [Related]
11. Role of high frequency ultrasonography in the evaluation of palpable breast masses in Chinese women: alternative to mammography?
Yang WT; Mok CO; King W; Tang A; Metreweli C
J Ultrasound Med; 1996 Sep; 15(9):637-44. PubMed ID: 8866446
[TBL] [Abstract][Full Text] [Related]
12. Palpable breast thickening: role of mammography and US in cancer detection.
Kaiser JS; Helvie MA; Blacklaw RL; Roubidoux MA
Radiology; 2002 Jun; 223(3):839-44. PubMed ID: 12034957
[TBL] [Abstract][Full Text] [Related]
13. False-negative rate of combined mammography and ultrasound for women with palpable breast masses.
Chan CH; Coopey SB; Freer PE; Hughes KS
Breast Cancer Res Treat; 2015 Oct; 153(3):699-702. PubMed ID: 26341750
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of the value of negative sonographic and mammographic findings in patients with palpable abnormalities of the breast.
Shetty MK; Shah YP
J Ultrasound Med; 2002 Nov; 21(11):1211-6; quiz 1217-9. PubMed ID: 12418762
[TBL] [Abstract][Full Text] [Related]
15. Reasons underlying negative mammography in patients with palpable breast cancer.
Coveney EC; Geraghty JG; O'Laoide R; Hourihane JB; O'Higgins NJ
Clin Radiol; 1994 Feb; 49(2):123-5. PubMed ID: 8124890
[TBL] [Abstract][Full Text] [Related]
16. Clinical Value of Mammography in the Evaluation of Palpable Breast Lumps in Women 30 Years Old and Older.
Brown AL; Phillips J; Slanetz PJ; Fein-Zachary V; Venkataraman S; Dialani V; Mehta TS
AJR Am J Roentgenol; 2017 Oct; 209(4):935-942. PubMed ID: 28777649
[TBL] [Abstract][Full Text] [Related]
17. [The value of aspiration cytology within the scope of triple diagnosis of palpable breast changes].
Schuhmann R; Hübner F; Brose C; Eckel S; Geier G; Kraus H; Schöndorf H; Schöndorf NK
Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):553-8. PubMed ID: 8543127
[TBL] [Abstract][Full Text] [Related]
18. Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 women.
Harvey JA; Nicholson BT; Lorusso AP; Cohen MA; Bovbjerg VE
AJR Am J Roentgenol; 2009 Dec; 193(6):1723-30. PubMed ID: 19933671
[TBL] [Abstract][Full Text] [Related]
19. The role of magnetic resonance imaging in patients with palpable breast abnormalities and negative mammographic and sonographic findings.
Yalniz C; Campbell D; Le-Petross C; Shin K; Bevers TB; Hess KR; Whitman GJ
Breast J; 2020 Jul; 26(7):1289-1295. PubMed ID: 32108973
[TBL] [Abstract][Full Text] [Related]
20. Microcalcifications of non-palpable breast lesions detected by ultrasonography: correlation with mammography and histopathology.
Huang CS; Wu CY; Chu JS; Lin JH; Hsu SM; Chang KJ
Ultrasound Obstet Gynecol; 1999 Jun; 13(6):431-6. PubMed ID: 10423808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
